In spite of significant progress towards malaria control and elimination achieved in South
America in the 2000s, this mosquito-transmitted tropical disease remains an important public …

Background Plasmodium vivax infects an estimated 7 million people every year. Previously,
vivax malaria was perceived as a benign condition, particularly when compared to …

Introduction: Relapses are important contributors to illness and morbidity in Plasmodium
vivax and P. ovale infections. Relapse prevention (radical cure) with primaquine is required …

Coevolution of humans and malaria parasites has generated an intricate balance between
the immune system of the host and virulence factors of the parasite, equilibrating maximal …

Background A very large biomass of intact asexual-stage malaria parasites accumulates in
the spleen of asymptomatic human individuals infected with Plasmodium vivax. The …

Background A vaccine to prevent infection and disease caused by Plasmodium vivax is
needed both to reduce the morbidity caused by this parasite and as a key component in …

Malaria can be caused by several Plasmodium species and the development of an effective
vaccine is challenging. Currently, the most effective tool to control the disease is the …

Malaria in Peru, dominated by Plasmodium vivax, remains a public health problem. The
1990s saw newly epidemic malaria emerge, primarily in the Loreto Department in the …

The overwhelming dominance of Duffy blood group negativity among most people living in
sub-Saharan Africa has been considered the basis of their protection from endemic …

During the last decade, the vast omics field has revolutionized biological research,
especially the genomics, transcriptomics and proteomics branches, as technological tools …